Skip to content
10-Q

Quarterly Report

BIOCUREX INC

0001554795-12-000148

← back to feed
Filed
Nov 14, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Nov 9, 2012 308.66M sh
Stock Repurchased Q3 2012 · Sep 30, 2012 $20K
Operating Cash Flow Q3 2012 · Sep 30, 2012 −$238.11K
Operating Cash Flow Q3 2012 · Sep 30, 2012 −$11.32M
Operating Cash Flow Q3 2012 · Sep 30, 2011 −$1.41M
Stockholders Equity Q3 2012 · Sep 30, 2012 −$2.43M
Stockholders Equity Q3 2012 · Dec 31, 2011 −$1.15M
Current Liabilities Q3 2012 · Sep 30, 2012 $2.59M
Current Liabilities Q3 2012 · Dec 31, 2011 $1.66M
Total Liabilities Q3 2012 · Sep 30, 2012 $2.59M
Total Liabilities Q3 2012 · Dec 31, 2011 $1.84M
Current Assets Q3 2012 · Sep 30, 2012 $24.4K
Current Assets Q3 2012 · Dec 31, 2011 $208.52K
Total Assets Q3 2012 · Sep 30, 2012 $160.82K
Total Assets Q3 2012 · Dec 31, 2011 $684.61K
Sga Expense Q3 2012 · Sep 30, 2012 $155.13K
Sga Expense Q3 2012 · Sep 30, 2012 $490.58K
Sga Expense Q3 2012 · Sep 30, 2012 $9.95M
Sga Expense Q3 2012 · Sep 30, 2011 $292.01K
Sga Expense Q3 2012 · Sep 30, 2011 $840.8K
Rd Expense Q3 2012 · Sep 30, 2012 $103.91K
Rd Expense Q3 2012 · Sep 30, 2012 $328.07K
Rd Expense Q3 2012 · Sep 30, 2012 $5.85M
Rd Expense Q3 2012 · Sep 30, 2011 $200.07K
Rd Expense Q3 2012 · Sep 30, 2011 $579.71K
Net Income Q3 2012 · Sep 30, 2012 −$746.03K
Net Income Q3 2012 · Sep 30, 2012 −$1.67M
Net Income Q3 2012 · Sep 30, 2012 −$28.06M
Net Income Q3 2012 · Sep 30, 2011 −$697.75K
Net Income Q3 2012 · Sep 30, 2011 −$1.97M
Operating Income Q3 2012 · Sep 30, 2012 −$618.79K
Operating Income Q3 2012 · Sep 30, 2012 −$1.38M
Operating Income Q3 2012 · Sep 30, 2012 −$21.46M
Operating Income Q3 2012 · Sep 30, 2011 −$629.34K
Operating Income Q3 2012 · Sep 30, 2011 −$1.91M
Revenue Q3 2012 · Sep 30, 2012 $7.93K
Revenue Q3 2012 · Sep 30, 2012 $30.81K
Revenue Q3 2012 · Sep 30, 2012 $1.5M
Short Term Debt Q3 2012 · Jun 30, 2012 $480K